Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Boston Scientific
(NY:
BSX
)
83.62
-0.40 (-0.48%)
Official Closing Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting Microbeads
September 20, 2021
Boston Scientific Corporation (NYSE: BSX) announced that the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres (TheraSphere treatment) met both primary...
Via
Benzinga
'Fast Money Halftime Report' Picks For September 15
September 15, 2021
On CNBC's "Fast Money Halftime Report," Karen Firestone said Charles Schwab (NYSE: SCHW) has a lot of new young traders who have larger accounts than Robinhood...
Via
Benzinga
Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study
August 30, 2021
Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer...
Via
Benzinga
Where Boston Scientific Stands With Analysts
August 21, 2021
Within the last quarter, Boston Scientific (NYSE:BSX) has ob...
Via
Benzinga
Post Market Studies Reinforce Unfavorable Risk-Benefit Profile For Boston Scientific's Vaginal Mesh
August 17, 2021
Final results from postmarket surveillance studies of Boston Scientific Corporation's (NYSE: BSX) transvaginal mesh for pelvic organ prolapse (POP) have reinforced...
Via
Benzinga
Boston Scientific's Exalt Model B Single-Use Bronchoscope Wins FDA Approval
August 11, 2021
The FDA has given 510(k) clearance for Boston Scientific Corp's (NYSE: BSX) Exalt Model B single-use bronchoscope for use in bedside procedures within the intensive...
Via
Benzinga
Exposures
Product Safety
Unusual Options Activity Insight: Boston Scientific
August 10, 2021
On Tuesday, shares of Boston Scientific (NYSE:BSX) saw unusu...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Why Boston Scientific Shares Are Trading Higher Today
July 27, 2021
Boston Scientific (NYSE:BSX) shares are trading higher after ...
Via
Benzinga
Boston Scientific Recalls Faulty Pacemakers Due To Risk of Incorrect Transition To Safety Mode
August 06, 2021
Boston Scientific Corporation (NYSE: BSX) is recalling Ingenio family pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) devices due to the risk of...
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Boston Scientific Starts Trial For EkoSonic Endovascular System In Patients With Pulmonary Embolism
August 04, 2021
Boston Scientific Corporation (NYSE: BSX) began enrollment for a clinical trial of its EkoSonic endovascular system (EKOS). Boston Scientific’s HI-PEITHO...
Via
Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Earnings Scheduled For July 27, 2021
July 27, 2021
Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million....
Via
Benzinga
'Fast Money Halftime Report' Picks For July 30
July 30, 2021
On CNBC's "Fast Money Halftime Report," Shannon Saccocia picked salesforce.com, inc. (NYSE: CRM) as her final trade. The company is going to report earnings in few...
Via
Benzinga
Stock Market Rally Pauses Near Highs Amid Earnings From Apple, Microsoft, Tesla, Amazon, Google, Facebook
July 30, 2021
The market rally paused on the key indexes amid earnings from Apple, Tesla and Amazon. But several stocks flashed buy signals.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Boston Scientific's Stock Is Trading Lower Today
May 26, 2021
Boston Scientific (NYSE:BSX) shares are trading lower af...
Via
Benzinga
Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript
July 27, 2021
BSX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Boston Scientific Earnings Top; BSX Stock Just Below Buy Point
July 27, 2021
Boston Scientific earnings and revenue beat Q2 views for the medtech giant. BSX stock rose to just below a buy point.
Via
Investor's Business Daily
Boston Scientific Earnings Exceed Expectations As Demand Picks Up, Raises FY21 Guidance
July 27, 2021
Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.1 billion in Q2 of 2021, beating the estimate of $2.9 billion. Sales increased 53.6% Y/Y on a...
Via
Benzinga
Recap: Boston Scientific Q2 Earnings
July 27, 2021
Shares of Boston Scientific (NYSE:BSX) fell 1.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year...
Via
Benzinga
Unusual Options Activity Insight: Boston Scientific
July 01, 2021
Boston Scientific (NYSE:BSX) shares experienced unusual options activity on Thursday. The stock price moved up to $43.24 following the option alert. Sentiment: BULLISH Option...
Via
Benzinga
Understanding Boston Scientific's Unusual Options Activity
June 30, 2021
Shares of Boston Scientific (NYSE:BSX) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $42.7. Sentiment:...
Via
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
July 27, 2021
This morning 85 companies set new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG). Intec...
Via
Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
Boston Scientific's Debt Overview
June 24, 2021
Over the past three months, shares of Boston Scientific (NYSE:BSX) rose by 12.01%. Before we understand the importance of debt, let us look at how much debt Boston...
Via
Benzinga
Better Buy: Medtronic or Boston Scientific?
June 03, 2021
Which one of these medical device makers is better poised for a breakout year?
Via
The Motley Fool
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2021
May 26, 2021
Upgrades Bernstein upgraded the previous rating for Wipro Ltd (NYSE:WIT) from Underperform to Market Perform. Wipro earned $0.07 in the fourth quarter, compared to $0.05...
Via
Benzinga
Pete Najarian Sees Unusual Options Activity In Boston Scientific And Deutsche Bank
May 24, 2021
On CNBC's "Fast Money Halftime Report," Pete Najarian spoke about unusually high options activity in Boston Scientific Corporation (NYSE: BSX) and Deutsche Bank AG (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.